Manipulation under anaesthetic (MUA) for the treatment of frozen shoulder is well established and effective however timing of surgery remains controversial. Intervention before 9 months has previously been shown to be associated with improved outcome. We test this theory by measuring Oxford Shoulder Score (OSS), re-MUA and subsequent surgery rate. A retrospective review of a prospectively collected, single surgeon, consecutive patient series revealed 244 primary frozen shoulders treated by MUA within 4 weeks of presentation. The mean duration of antecedent symptoms was 28 weeks (95% CI 4-44 weeks) and time to follow up was 26 days (95% CI 11-41 days). The mean OSS improved by 16 points (2-tailed t test p< 0.001) with a mean follow up OSS of 43 (95% CI 38-48). 195 shoulders were manipulated before 38 weeks (9 months) and had the same mean change in OSS (16) as the 49 shoulders manipulated after 38 weeks. 48 shoulders, including 15 diabetic shoulders required further MUA. 8 shoulders had subsequent surgery. These events were also independent of antecedent symptom duration. Early MUA does not appear to produce improved outcomes when compared to later intervention but we note does result in an earlier return to function.
The effect of timing of a manipulation under
anaesthetic (MUA) and injection of corticosteroid and local anaesthetic for
the treatment of frozen shoulder has attracted little attention
to date. All studies describe a period of conservative treatment
before proceeding to an MUA. Delay has been associated with a poorer
outcome. We present a retrospective review of a prospectively collected,
single-surgeon, consecutive series of 246 patients with a primary
frozen shoulder treated by MUA within four weeks of presentation.
The mean duration of presenting symptoms was 28 weeks (6 to 156),
and time to initial post-operative assessment was 26 days (5 to
126). The Oxford shoulder score (OSS) improved by a mean of 16 points
(Wilcoxon signed-ranks test,
p <
0.001) with a mean OSS at this time of 43 (7 to 48). Linear
regression analysis showed no correlation between the duration of
presenting symptoms and OSS at initial follow-up
(R2 <
0.001) or peri-operative change in OSS (R2 <
0.001)
or OSS at long-term follow-up
(R2 <
0.03). Further analysis at a mean of 42 months (8 to 127)
revealed a sustained improvement with a mean OSS of 44 (16 to 48). A good outcome follows an MUA and injection of corticosteroid
and local anaesthetic in patients with primary frozen shoulder,
independent of the duration of the presenting symptoms, and this
improvement is maintained in the long term.